Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $3.26 million versus the consensus estimate of $9.35 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.